Jennifer Peos, MD
Internal Medicine · Livingston, NJNPI 1710986195
Payments from drug & device makers
Across 260 payments — averaging $14.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- AstraZeneca$586
- Daiichi Sankyo Inc.$474
- Incyte Corporation$377
- Takeda Pharmaceuticals U.S.A., Inc.$177
- Johnson & Johnson$159
- plus $814 from 26 others
What the payments were for
- Food & beverage$3,78398%
- Education$852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 94 | $1,281 |
| AstraZeneca | 36 | $586 |
| Daiichi Sankyo Inc. | 35 | $474 |
| Incyte Corporation | 25 | $377 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $177 |
| Johnson & Johnson | 10 | $159 |
| Lundbeck LLC | 5 | $83 |
| Novartis | 4 | $72 |
| EUSA Pharma (US) LLC | 4 | $61 |
| AMAG Pharmaceuticals, Inc. | 4 | $55 |
| Biogen | 3 | $47 |
| Apellis Pharmaceuticals, Inc. | 3 | $46 |
| Dova Pharmaceuticals | 2 | $43 |
| Invivyd Inc | 2 | $37 |
| Octapharma USA, Inc. | 2 | $32 |
| Rigel Pharmaceuticals, Inc. | 2 | $30 |
| Global Blood Therapeutics, Inc. | 2 | $28 |
| Bristol Myers Squibb | 2 | $27 |
| Sandoz | 1 | $27 |
| AbbVie | 2 | $25 |
| Otsuka America Pharmaceutical, Inc. | 2 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $20 |
| Radius Health, Inc. | 1 | $19 |
| GSK | 1 | $18 |
| Biocon Biologics Inc | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $15 |
| Pfizer | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
How this compares
$3,868 in reported general payments places this provider in the 85th percentile of 4,032 internal medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spiriva HandihalerTiotropium Bromide | 12 | $6,082 |
| Telmisartan | 33 | $1,932 |
| Novolog FlexpenInsulin Aspart | 12 | $1,646 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 27 | $1,430 |
| Levothyroxine Sodium | 91 | $1,426 |
| Olmesartan Medoxomil | 35 | $1,371 |
| Atorvastatin Calcium | 124 | $1,235 |
| Losartan Potassium | 64 | $1,131 |
| Valsartan | 19 | $1,106 |
| Amlodipine Besylate | 141 | $1,032 |
| Pantoprazole Sodium | 33 | $947 |
| Simvastatin | 66 | $839 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $838 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 16 | $736 |
| Metoprolol Succinate | 59 | $704 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Livingston
- Samar HameedLivingston$3.6M
- Martin BedigianLivingston$240K
- Noah RosenbergLivingston$144K
- Sanjiv SharmaToms River$33.9M
- Jeffrey CarsonNew Brunswick$13.8M
- Samer HaddadHamilton$6.8M
- Magdy ShenoudaWall$3.7M
- Jane RohlfTrenton$2.7M
- Mohammed NisarEdison$2.6M
- Michael CasserNew Milford$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.